Gilead Sciences Inc. Canadian Depositary Receipt (GIS0)

Profile

https://www.gilead.com

Gilead Sciences Inc. Canadian Depositary Receipt is a Canadian-listed security that provides exposure to Gilead Sciences Inc., a global biopharmaceutical company headquartered in Foster City, California. Through this Canadian Depositary Receipt structure, investors can access the economic performance of Gilead Sciences in Canadian dollars, with each receipt representing a variable interest in the underlying U.S. shares, adjusted via a CDR ratio mechanism. Gilead Sciences today focuses on discovering, developing, and commercializing prescription medicines addressing areas of unmet medical need, particularly in virology, oncology, and inflammatory diseases. Its portfolio includes branded therapies for HIV, viral hepatitis, liver disease, and certain cancers, serving healthcare systems and patients across North America, Europe, and other international markets. The Gilead Sciences Inc. Canadian Depositary Receipt thus functions as a localized vehicle that mirrors the business performance of a major global biopharmaceutical innovator within the Canadian equity market framework.